The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000544370p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
10/04/2026
Date registered
Help: Date registered
30/04/2026
Date last updated
Help: Date last updated
30/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
30/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Effects of limb immobilisation, contralateral strength training, and prism-based visual feedback on muscle strength and neural function in healthy adults.
Scientific title
A randomised controlled trial investigating the effects of short-term limb immobilisation and contralateral strength training, with and without prism-augmented visual feedback, on corticospinal, cortico-reticulospinal, and motor unit adaptations in healthy adults.
Additional trial identifiers [1] 316999 0
not applicable
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Musculoskeletal injury 341479 0
Limb immobilisation 341480 0
Neuromuscular mechanisms of limb immobilisation 341481 0
strength maintenance 341688 0
Condition category
Condition code
Musculoskeletal 337571 337571 0 0
Other muscular and skeletal disorders
Physical Medicine / Rehabilitation 337674 337674 0 0
Other physical medicine / rehabilitation

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Participants will be allocated to one of four conditions involving limb immobilisation and/or neuromuscular interventions. Immobilisation will be achieved via a unilateral wrist brace worn continuously to restrict movement and maintain the joint in a neutral position for up to 14 days. Intervention groups will undertake supervised unilateral resistance training (cross-education) of the non-immobilised limb, consisting of upper-limb exercises performed at ~80–85% one-repetition maximum, 4 sets of 6–8 repetitions, three sessions per week over 14 days. One intervention arm will additionally incorporate prism-augmented visual feedback, with participants wearing prism glasses during training to laterally displace the visual field and create the illusion of movement in the immobilised limb.

All training sessions will be delivered face-to-face on an individual basis by trained research personnel with expertise in neuromuscular physiology and resistance training. Sessions will be conducted in a controlled laboratory setting. Adherence will be monitored through direct supervision of all training sessions and compliance with immobilisation protocols, with attendance and protocol deviations recorded.
Intervention code [1] 333756 0
Rehabilitation
Description of the comparator or control
The comparator consists of two control conditions: (1) a no-intervention group in which participants do not undergo limb immobilisation, strength training, or prism exposure, and (2) an immobilisation-only group, in which participants undergo unilateral wrist immobilisation using a brace for up to 14 days without additional intervention. These conditions serve as baseline and mechanistic comparators to account for natural variability and to isolate the effects of immobilisation from the active interventions.

Immobilisation will be prescribed and monitored by trained research personnel with expertise in neuromuscular physiology. The control condition involves no active treatment delivery, while immobilisation is applied in a laboratory setting with instructions provided face-to-face and maintained continuously outside the laboratory. Duration is continuous immobilisation for up to 14 days, with no training sessions.

Adherence will be monitored through participant instructions, regular check-ins, and compliance reporting, with deviations from immobilisation recorded.
Control group
Active

Outcomes
Primary outcome [1] 345051 0
Maximum voluntary force production, Baseline, 3, 8, 24 hours , 7 and 14 days post immobilisation
Timepoint [1] 345051 0
Baseline, 3, 8, 24 hours , 7 and 14 days post immobilisation
Primary outcome [2] 345052 0
Rate of Force Development , Baseline, 3, 8, 24 hours , 7 and 14 days post immobilisation
Timepoint [2] 345052 0
Baseline, 3, 8, 24 hours , 7 and 14 days post immobilisation
Secondary outcome [1] 460319 0
Corticospinal Excitability
Timepoint [1] 460319 0
Pre, 3, 8, 24 hours, 7 and 14 days post immobilisation
Secondary outcome [2] 460320 0
Reticulospinal tract excitability
Timepoint [2] 460320 0
Pre, 3, 8, 24 hours post, 7 and 14 days post immobilisation.

Eligibility
Key inclusion criteria
• Healthy adults aged 18–65 years
• Eligible for TMS and resistance training
• Right-handed (for standardisation)
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
• Neurological disorders (e.g. epilepsy, stroke)
• Implanted medical devices
• Central Nervous System (CNS) medications
• History of seizures or migraine
• Current or recent resistance training

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed. Participants will be randomly allocated to study groups following eligibility assessment; however, due to the open-label design and the nature of the interventions (e.g., limb immobilisation, supervised training, and prism exposure), the investigator responsible for enrolment and allocation will be aware of group assignment at the time of allocation.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Participants will be randomly allocated to one of four groups using a computer-generated randomisation sequence with permuted blocks to ensure equal group sizes (allocation ratio 1:1:1:1). No stratification factors will be applied.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?

The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Not applicable as it is not a drug trial
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
Linear mixed-effects models will be used with:
• fixed effects: group, time, group × time
• random effect: participant
Primary interest: group × time interaction
Significance: p < 0.05


Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment postcode(s) [1] 45713 0
3199 - Frankston

Funding & Sponsors
Funding source category [1] 321596 0
University
Name [1] 321596 0
Monash University
Country [1] 321596 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Country
Australia
Secondary sponsor category [1] 324405 0
None
Name [1] 324405 0
Address [1] 324405 0
Country [1] 324405 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320123 0
Monash University Human Research Ethics Committee
Ethics committee address [1] 320123 0
Ethics committee country [1] 320123 0
Australia
Date submitted for ethics approval [1] 320123 0
09/04/2026
Approval date [1] 320123 0
Ethics approval number [1] 320123 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149510 0
A/Prof Dawson Kidgell
Address 149510 0
Monash University-Peninsula Campus, 47-49 Moorooduc Hwy, Frankston, Victoria, 3199
Country 149510 0
Australia
Phone 149510 0
+61433185951
Fax 149510 0
Email 149510 0
Contact person for public queries
Name 149511 0
Chu Gan
Address 149511 0
Monash University - Peninsula Campus, 47-49 Moorooduc Hwy, Frankston, Victoria, 3199
Country 149511 0
Australia
Phone 149511 0
+61 493498776
Fax 149511 0
Email 149511 0
Contact person for scientific queries
Name 149512 0
Dawson Kidgell
Address 149512 0
Monash University - Peninsula Campus, 47-49 Moorooduc Hwy, Frankston, Victoria, 3199
Country 149512 0
Australia
Phone 149512 0
+61433185951
Fax 149512 0
Email 149512 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
• Studies testing whether findings can be repeated or confirmed
• Teaching research methods or developing new statistical techniques
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Email to A/Prof Dawson Kidgell
Email Address: [email protected]


Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.